Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?
Del Bano J, Chames P, Baty D, Kerfelec B
Patrick Chames
Responsable d'équipe Directeur de Recherche CNRS (DR2) Equipe
Publications
Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brain.
Meng J, Xu C, Lafon PA, Roux S, Mathieu M, Zhou R, Scholler P, Blanc E, Becker JAJ, Le Merrer J, González-Maeso J, Chames P, Liu J, Pin JP, Rondard P
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.
Tapia-Galisteo A, Sánchez Rodríguez Í, Aguilar-Sopeña O, Harwood SL, Narbona J, Ferreras Gutierrez M, Navarro R, Martín-García L, Corbacho C, Compte M, Lacadena J, Blanco FJ, Chames P, Roda-Navarro P, Álvarez-Vallina L, Sanz L